Intuitive Surgery tightened its 2026 surgical volume growth forecast for its Da Vinci robotic surgical system on Tuesday. The increase in surgery volume is a key indicator for Intuitive Surgery, as operations performed using its Da Vinci system generate recurring sales of devices and accessories, which is the company's biggest source of revenue. The medical device maker's stock price fell about 7% in after-hours trading, and the company expects global Leonardo da Vinci surgery volume growth to be closer to the midpoint of its 14% to 15% forecast range. Previously, the forecast range given by the company was 13.5% to 15.5% in the third quarter. The growth rate of Leonardo da Vinci surgery volume in the US market was 10%, while the growth rate for markets outside the US was 20%.

Intuitive Surgery tightened its 2026 surgical volume growth forecast for its Da Vinci robotic surgical system on Tuesday. The increase in surgery volume is a key indicator for Intuitive Surgery, as operations performed using its Da Vinci system generate recurring sales of devices and accessories, which is the company's biggest source of revenue. The medical device maker's stock price fell about 7% in after-hours trading, and the company expects global Leonardo da Vinci surgery volume growth to be closer to the midpoint of its 14% to 15% forecast range. Previously, the forecast range given by the company was 13.5% to 15.5% in the third quarter. The growth rate of Leonardo da Vinci surgery volume in the US market was 10%, while the growth rate for markets outside the US was 20%.